Form4insider filings, from the source

SEC Form 4 · accession 0001055726-17-000006

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2017M5,334—A728,956D
Common StockF2Mar 9, 2017M10,000—A738,956D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2017M5,334D——Common Stock5,33410,666D
Restricted Stock UnitF2—Mar 9, 2017M10,000D——Common Stock10,00020,000D
Common Stock OptionF3$6.68Mar 10, 2017A60,000AMar 10, 2017Mar 10, 2027Common Stock60,00060,000D
Restricted Stock UnitF4—Mar 10, 2017A35,000A——Common Stock35,00035,000D

Explanation of responses